Automated description from the Alliance of Genome Resources
Predicted to have caffeine oxidase activity; heme binding activity; and monooxygenase activity. Predicted to be involved in several processes, including epoxygenase P450 pathway; exogenous drug catabolic process; and xenobiotic metabolic process. Predicted to localize to the cytoplasm and intracellular membrane-bounded organelle. Human ortholog(s) of this gene implicated in several diseases, including eosinophilic esophagitis; glucose metabolism disease (multiple); hypertension; multiple myeloma; and sickle cell anemia. Orthologous to human CYP2C19 (cytochrome P450 family 2 subfamily C member 19) and CYP2C9 (cytochrome P450 family 2 subfamily C member 9).